Under the terms of the agreement, Tengram will run the company as an independent and stand-alone entity based in New York City. Closing is expected to be completed by the end of November.
“We are delighted to add RéVive to our strong and growing portfolio of beauty brands,” said Richard Gersten, a partner at Tengram Capital. “As an investor in consumer brands with a deep knowledge in beauty, I have watched RéVive for a long time. We believe it is a gem, thanks to its founder Dr. Gregory Bays Brown, its exceptional products based on Nobel prize-winning technologies, a loyal consumer following, and its impressive distribution. The RéVive brand has strong growth prospects, and we look forward to investing in key areas to enable the brand to thrive.”
Tengram Capital is a private equity firm that invests in companies in the branded consumer products and retail space and acts as a catalyst to drive growth. Its current beauty portfolio includes Nest Fragrances, Algenist, specialty beauty retailer Cos Bar, and natural beauty brand This Works.
The new company will be led by Elana Drell Szyfer, who worked with Tengram as the CEO of Laura Geller New York, which Tengram sold in 2016. She is currently an operating advisor to the firm. Szyfer’s industry experience includes executive roles on the Lancôme and Estee Lauder brands.
She will be joined by John Elmer in the role of CFO and COO of RéVive and Mary Rodrigues as SVP of marketing and Ecommerce. Elmer served in this same role at Laura Geller with Drell Szyfer. Prior to Laura Geller, he was the CFO/COO for Carol’s Daughter and was instrumental in the brand’s growth, resulting in a sale to L’Oreal in 2014. Rodrigues is an experienced beauty industry executive.
To ensure continuity for customers, Shiseido Americas will continue to provide supply chain, distribution and other support services during the transition.
RéVive was acquired by Shiseido Americas as part of its 2016 acquisition of Gurwtich Products LLC from Alticor. Terms of the sale were not disclosed.